Recall: D-0383-2026

Class II - Potentially Harmful

Class IIClassification

2026-02-17Initiated

OngoingStatus

The Harvard Drug Group LLCFirm

Product

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

Reason

Defective container; inadequately sealed blister packaging.

Distribution

Nationwide US.

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.